Compare, Analyse Cadila Healthcare with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ADCOCK INGRAM (S. Africa) - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   ADCOCK INGRAM
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
ADCOCK INGRAM
Jun-14
CADILA HEALTHCARE/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs352376-   
Low Rs207271-   
Sales per share (Unadj.) Rs139.2111.9-  
Earnings per share (Unadj.) Rs11.8-28.2-  
Cash flow per share (Unadj.) Rs18.6-23.4-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs101.487.9-  
Shares outstanding (eoy) m1,023.74168.78-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.02.9 69.4%   
Avg P/E ratio x23.7-11.5 -206.8%  
P/CF ratio (eoy) x15.0-13.9 -108.6%  
Price / Book Value ratio x2.83.7 74.8%  
Dividend payout %29.80-   
Avg Mkt Cap Rs m286,03354,660 523.3%   
No. of employees `00013.44.3 312.3%   
Total wages/salary Rs m24,1453,431 703.8%   
Avg. sales/employee Rs Th10,632.74,400.6 241.6%   
Avg. wages/employee Rs Th1,801.2799.1 225.4%   
Avg. net profit/employee Rs Th898.5-1,108.8 -81.0%   
INCOME DATA
Net Sales Rs m142,53118,892 754.5%  
Other income Rs m1,139132 861.0%   
Total revenues Rs m143,67019,024 755.2%   
Gross profit Rs m24,198-3,274 -739.1%  
Depreciation Rs m6,965815 854.2%   
Interest Rs m3,418512 667.9%   
Profit before tax Rs m14,954-4,469 -334.6%   
Minority Interest Rs m288-12 -2,312.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,198279 1,145.3%   
Profit after tax Rs m12,044-4,760 -253.0%  
Gross profit margin %17.0-17.3 -98.0%  
Effective tax rate %21.4-6.2 -342.2%   
Net profit margin %8.5-25.2 -33.5%  
BALANCE SHEET DATA
Current assets Rs m87,15413,837 629.9%   
Current liabilities Rs m82,6947,785 1,062.2%   
Net working cap to sales %3.132.0 9.8%  
Current ratio x1.11.8 59.3%  
Inventory Days Days71111 64.4%  
Debtors Days Days94124 75.7%  
Net fixed assets Rs m133,2368,065 1,652.0%   
Share capital Rs m1,02488 1,167.5%   
"Free" reserves Rs m102,7330-   
Net worth Rs m103,75714,828 699.7%   
Long term debt Rs m32,1465,211 616.9%   
Total assets Rs m236,86628,011 845.6%  
Interest coverage x5.4-7.7 -69.5%   
Debt to equity ratio x0.30.4 88.2%  
Sales to assets ratio x0.60.7 89.2%   
Return on assets %6.5-15.2 -43.0%  
Return on equity %11.6-32.1 -36.2%  
Return on capital %13.7-19.8 -69.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m38,2480-   
CASH FLOW
From Operations Rs m25,0541,613 1,553.7%  
From Investments Rs m-10,123-495 2,044.5%  
From Financial Activity Rs m-10,9424,729 -231.4%  
Net Cashflow Rs m3,9895,847 68.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.19 Rs / ZAR

Compare CADILA HEALTHCARE With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: ORCHID PHARMA  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  NEULAND LABS  STERLING BIOTECH  



Today's Market

Sensex Jumps 500 Points; Dow Futures Down by 31 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 598 points, up 1.2% at 49,331 levels.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Revealing at 5pm Today: The Great Indian Wealth Project
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CADILA HEALTHCARE SHARE PRICE


May 17, 2021 02:30 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS